Powered by RedCircle
Strong science doesn't automatically lead to commercial success. There's a gap between breakthrough research and real-world impact that trips up even the most promising technologies. Business development is the art of building relationships, positioning innovations, and navigating markets — and that’s where many tech transfer offices find themselves stretched thin or stuck.
Ernesto Chanona, the CEO of American Business Development, knows both sides of this world. He earned his PhD in pharmacology and did postdoctoral work developing immunotherapies at the National Cancer Institute. But instead of continuing down the traditional academic track, he made a sharp turn into business development at Maryland's Department of Commerce, helping life science companies expand internationally. Years later, he founded American Business Development to work with tech transfer offices, startups, and foreign companies trying to break into the U.S. market.
In this conversation, he walks through what business development actually looks like in life sciences, including equal parts sales, technical expertise, and strategic consulting. We talk about the bandwidth crunch hitting tech transfer offices, building frameworks that scale, and why he says the best-marketed technology often wins over the best science. Canona shares hard-won lessons about pitching investors, navigating the fragmented U.S. healthcare system, and why his best advice is deceptively simple: Ask for help. People in this field genuinely want technologies to succeed, and many innovators get stuck trying to figure it all out alone.
Find and share more Transfer Files conversations on the FLC website, YouTube, Apple, Spotify, and other popular podcast platforms. Subscribe to stay updated on the latest in federal tech transfer!
Resources:
In This Episode:
[02:08] Ernesto's unconventional path from pharmacology PhD to business development.
[06:58] Defining what a business developer does in life sciences—more than just sales.
[07:49] The three pillars: salesperson, subject matter expert, and consultant.
[11:20] Why business developers hold critical relationships that can't easily be replaced.
[13:45] The underappreciated role of federal labs in the innovation ecosystem.
[17:04] Where tech transfer offices struggle most with business development.
[19:00] Bandwidth challenges and why being short-staffed creates the biggest gaps.
[20:00] First steps when evaluating whether a technology needs partners or better positioning.
[21:13] Building scalable BD frameworks—internal operations and external consistency.
[22:53] What separates commercially ready technologies from those needing development.
[23:44] The role of luck and market validation in commercial readiness.
[24:46] Deploying demo units to universities for voice-of-customer feedback.
[26:03] Balancing high-risk innovations with near-market technologies.
[28:20] The biggest mistakes organizations make when pitching to investors.
[28:51] Why the size of your ask matters more than you think.
[30:12] The importance of detailed, well-researched outbound messaging.
[33:08] ABD Capital Connect event during J.P. Morgan Healthcare Week.
[35:02] International expansion challenges and competition from China.
[36:28] Why the fragmented U.S. healthcare system confuses foreign companies.
[38:18] The problem with one-person in-country hires versus team-based approaches.
[39:40] Why the best marketed technology wins, not just the best science.
[42:01] Final advice: It takes a village, so leverage your network and ask for help.
[43:06] How willing people are to help when you're motivated to bring something to market.